Taiwan Cell Manufacturing Company Ltd.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
We specialize in providing high-quality viral vectors (especially lentiviral vectors, LVVs) and cell therapy products, which can be tailored to your specific needs. LVVs play a critical role in the genetic modification of T cells (such as Chimeric Antigen Receptor T cells / CAR-T). We offer advanced LVV manufacturing solutions that provide comprehensive support for the development of genetically modified T cells, from research and development (R&D) to full-scale commercialization.
Furthermore, our expertise also covers the manufacturing of non-genetically modified cells, such as dendritic cells (DCs), cytokine-induced killer cells (CIKs), natural killer cells (NKs), and stem cells. We deeply understand the complexity of regulatory compliance; therefore, each of our CDMO services is equipped with comprehensive regulatory support to assist you in perfecting your CMC (Chemistry, Manufacturing, and Controls) documentation.
From pioneering research to life-changing therapies, Taiwan Cell Manufacturing Company Ltd. is your reliable partner in developing next-generation treatments. Let us work together to advance the future of medicine.
(The content above was translated by AI.)
Furthermore, our expertise also covers the manufacturing of non-genetically modified cells, such as dendritic cells (DCs), cytokine-induced killer cells (CIKs), natural killer cells (NKs), and stem cells. We deeply understand the complexity of regulatory compliance; therefore, each of our CDMO services is equipped with comprehensive regulatory support to assist you in perfecting your CMC (Chemistry, Manufacturing, and Controls) documentation.
From pioneering research to life-changing therapies, Taiwan Cell Manufacturing Company Ltd. is your reliable partner in developing next-generation treatments. Let us work together to advance the future of medicine.
(The content above was translated by AI.)
Founded Year
2021
Unified Business No.
91062335
Status
Active
Number of Employees
0
Total Paid-in
Capital
505,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
tcmc is a biotechnology company focusing on the field of cell and gene therapy, providing comprehensive contract development and manufacturing organization (CDMO) services. We can support the CMC development required for IND applications, as well as comprehensive solutions for the clinical trial and commercial manufacturing stages.
Leveraging our professional capabilities in large-scale process development, GMP manufacturing, and viral vector technology (vectorology) development, tcmc has built a robust and diverse manufacturing platform capable of supporting the development and production of various cell and gene therapy products. Based on the support of policies and regulations, we are committed to helping clients accelerate product development timelines while effectively reducing manufacturing costs.
(The content above was translated by AI.)
Leveraging our professional capabilities in large-scale process development, GMP manufacturing, and viral vector technology (vectorology) development, tcmc has built a robust and diverse manufacturing platform capable of supporting the development and production of various cell and gene therapy products. Based on the support of policies and regulations, we are committed to helping clients accelerate product development timelines while effectively reducing manufacturing costs.
(The content above was translated by AI.)
